arrow
T

Teele Kuusk

Cambridge University Hospitals NHS Foundation Trust
H指数:23
被引数:4,838

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Management of Lymph Node–Positive Renal Cell Carcinoma: Updated Recommendations from the European Association of Urology Renal Cell Carcinoma Guidelines Panel

淋巴结阳性肾细胞癌的管理:欧洲泌尿外科学会肾细胞癌指南小组的更新建议

2026-05-120
PRE
Cambridge kidney One-Stop Mass Investigation Clinic (CkOSMIC): A Nonrandomised Feasibility Study

剑桥肾脏一站式质量检查诊所(CkOSMIC):一项非随机可行性研究

2025-10-140
OAAI
Hospital Volume as a Determinant of Outcomes After Partial Nephrectomy: A Systematic Review by the European Association of Urology Renal Cell Carcinoma Guidelines Panel

医院手术量作为部分肾切除术预后的决定因素:欧洲泌尿外科学会肾细胞癌指南专家组系统评价

2025-06-010
PRE
Updated European Association of Urology Guidelines on the Use of Adjuvant Immune Checkpoint Inhibitors and Subsequent Therapy for Renal Cell Carcinoma

更新版欧洲泌尿外科学会关于肾细胞癌辅助免疫检查点抑制剂及后续治疗指南

2025-02-011
PRE
A Renewal of the TNM Staging System for Patients with Renal Cancer To Comply with Current Decision-making: Proposal from the European Association of Urology Guidelines Panel
2023-03-010
PRE
European Association of Urology Guidelines Panel on Renal Cell Carcinoma Update on the New World Health Organization Classification of Kidney Tumours 2022: The Urologist?s Point of View
2023-02-0114
PRE
The 2022 Updated European Association of Urology Guidelines on the Use of Adjuvant Immune Checkpoint Inhibitor Therapy for Renal Cell Carcinoma

2022更新的欧洲泌尿外科协会肾细胞癌辅助免疫检查点抑制剂治疗指南

2023-01-0132
OA
A Renewal of the TNM Staging System for Patients with Renal Cancer To Comply with Current Decision-making: Proposal from the European Association of Urology Guidelines Panel
2023-01-016
OA
2021 Updated European Association of Urology Guidelines on the Use of Adjuvant Pembrolizumab for Renal Cell Carcinoma

2021更新欧洲泌尿外科协会关于使用辅助帕博利珠单抗治疗肾细胞癌的指南

2022-02-0127
PRE
The 2021 Updated European Association of Urology Guidelines on Renal Cell Carcinoma: Immune Checkpoint Inhibitor-based Combination Therapies for Treatment-naive Metastatic Clear-cell Renal Cell Carcinoma Are Standard of Care
2021-10-01115
PREAI